C hronic hypertension is a major risk factor for carotid vascular disease and stroke. 1, 2 For reasons that are not clear, hypertension is more strongly associated with stroke than with myocardial infarction. 3 Recent findings suggest that carotid artery disease (carotid wall thickening) is associated with impairment of endothelium-dependent relaxation in patients with hypertension. 4 In addition, a genetic analysis demonstrated cosegregation of impaired endotheliumdependent relaxation and a stroke-prone phenotype in chronically hypertensive rats. 5 These findings reaffirm the importance of studying mechanisms of endothelial dysfunction in carotid artery and cerebral blood vessels under pathophysiological conditions, including hypertension.
At present, our understanding of changes in carotid and cerebral vascular function during hypertension is based almost exclusively on studies in spontaneously hypertensive rats (SHR) and stroke-prone spontaneously hypertensive rats (SHRSP), models in which hypertension has an unknown etiology and in which the genetic background is dissimilar to the most commonly used normotensive control, the WistarKyoto rat (WKY). 6 The first goal of the present study was to
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examine vascular function in a novel, defined model of hypertension, a transgenic mouse that overexpresses both human renin and human angiotensinogen genes (Rϩ/Aϩ). [7] [8] [9] Using these mice, we examined the hypothesis that endothelium-dependent relaxation is impaired during hypertension. Some previous studies suggest that endothelial dysfunction during hypertension may involve production of an endothelium-derived contracting factor produced through the cyclooxygenase pathway. 10 Thus, the second goal of the present study was to examine the hypothesis that impaired endothelial function in Rϩ/Aϩ mice can be improved with indomethacin, an inhibitor of this enzyme system.
Materials and Methods

Animals
The experimental protocol was approved by our institution's animal care and use committee. All breeding and genotyping was performed in the transgenic animal facility (directed by C.D.S.), located in a virus-and pathogen-free animal care facility. Double transgenic mice (Rϩ/Aϩ) were generated by crossbreeding human renin (Rϩ) mice with human angiotensinogen (Aϩ) mice, as we have reported. 8, 9 The presence of the transgenes was assessed by gene-and species-specific polymerase chain reaction of DNA isolated from tail biopsy samples, as described previously. 8, 9 We and others have found that the most accurate measurements of arterial pressure in mice are obtained with chronic indwelling catheters in conscious animals. We have shown previously 8, 9 that mean arterial pressure in conscious Rϩ/Aϩ mice (measured with a chronic indwelling carotid catheter) is approximately 155 to 160 mm Hg compared with approximately 115 to 120 mm Hg in control animals (RϪ/AϪ, nontransgenic controls). 8, 9 Because our goal was to study function of the carotid artery in these experiments, we did not implant carotid catheters in these mice. There are no differences in blood pressure between RϪ/AϪ and single transgenic mice (Rϩ/AϪ or RϪ/Aϩ) owing to the strict species specificity in the enzymatic reaction between renin and angiotensinogen. 8 Because of this specificity, mouse renin does not cleave human angiotensinogen, and human renin does not cleave mouse angiotensinogen. 8 Because blood pressure is the same in all 3 mice, RϪ/AϪ, Rϩ/AϪ, and RϪ/Aϩ mice were all used as controls in the present study. Control and Rϩ/Aϩ mice averaged 7.5 months of age. Body weight of control and Rϩ/Aϩ mice was 26Ϯ4 and 25Ϯ3 g, respectively.
Vascular Ring Preparation
Mice (male and female) were anesthetized with pentobarbital (75 to 100 mg/kg IP), and both carotid arteries were quickly removed and placed in Krebs' buffer with the following ionic composition (mmol/L): NaCl 118.3, KCl 4.7, CaCl 2 2.5, MgSO 4 1.2, KH 2 PO 4 1.2, NaHCO 3 25, glucose 11. Loose connective tissue in the adventitia was removed, and each carotid artery was cut into 2 rings (3 to 4 mm in length). Vascular rings were suspended in an organ bath containing 25 mL Krebs' solution maintained at 37°C. The rings were connected to a force transducer to measure isometric tension (contraction and relaxation). Resting tension was increased stepwise to reach the final tension of 0.2 to 0.25 g, and the rings were allowed to equilibrate for at least 60 minutes. This amount of resting tension is optimal for contraction in these arteries.
Protocols
Vessels were contracted submaximally (40% to 50% of maximum) with the thromboxane A 2 mimetic U46619 (9,11-dideoxy-11a,9a-epoxy-methanoprostaglandin F 2␣ ) (0.2 to 0.4 g/mL) or prostaglandin F 2␣ (PGF 2␣ ) (10 to 50 mol/L). After a stable contraction plateau was reached, dose-response curves were obtained for acetylcholine, sodium nitroprusside, and papaverine. Acetylcholine was used to assess endothelial function, and nitroprusside and papaverine were used to examine direct effects on smooth muscle. We have shown previously that responses of the carotid artery to acetylcholine are mediated by release of nitric oxide by endothelial nitric oxide synthase and activation of soluble guanylate cyclase. 11 In some experiments we examined effects of indomethacin (10 mol/L) on vasomotor responses. We have used these techniques for studies of mouse vessels in vitro previously. [11] [12] [13] [14] At the end of each experiment, we obtained a dose-response curve for the carotid artery for U46619 to determine maximal contractile responses. U46619 produces greater maximal contraction of mouse carotid arteries than high concentrations of KCl.
Statistical Analysis
All data are expressed as meanϮSE. Vasorelaxation responses were expressed as the percent relaxation from the amount of precontraction produced by U46619 or PGF 2␣ . Comparisons were made with ANOVA or a t test, as appropriate. Statistical significance was accepted at PϽ0.05.
Results
Vascular Responses in Control Mice and R؉/A؉ Mice
Responses of the carotid artery to acetylcholine were similar in RϪ/AϪ, Rϩ/AϪ, and RϪ/Aϩ mice. Thus, these data were pooled into a single control group (nϭ15). In vessels from control mice, acetylcholine produced concentrationdependent relaxation (Figure 1 ). Relaxation in response to acetylcholine was impaired in carotid arteries from Rϩ/Aϩ mice (nϭ13), particularly at higher concentrations of acetylcholine ( Figure 1 ). In contrast to arteries from control mice, higher concentrations of acetylcholine frequently caused transient contractions of the carotid artery from Rϩ/Aϩ mice (see Figure 2 , top tracing, for an example).
Nitroprusside ( Figure 3 ) and papaverine ( Figure 4 ) produced similar relaxation of carotid arteries from control and Rϩ/Aϩ mice. Contraction of the carotid artery in response to U46619 was also similar in control and Rϩ/Aϩ mice ( Figure  5 ). These findings indicate that impaired responses to acetylcholine in Rϩ/Aϩ mice were selective for the endotheliumdependent agonist acetylcholine and were not due to a generalized, nonspecific alteration in vascular function.
Effect of Indomethacin on Vascular Responses
In control mice, relaxation in response to acetylcholine was similar in the absence and presence of indomethacin ( Figure  6 , left panel). Contraction of the carotid artery in response to 
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U46619 was also not affected by indomethacin in control mice (data not shown).
In Rϩ/Aϩ mice, relaxation in response to acetylcholine was enhanced in the presence of indomethacin ( Figure 6 , right panel). Transient contractions of the carotid artery from Rϩ/Aϩ mice in response to higher concentrations of acetylcholine were absent in the presence of indomethacin (see Figure 2 , bottom tracing, for an example). In contrast to effects of indomethacin on responses to acetylcholine in Rϩ/Aϩ mice, indomethacin did not alter contraction of the carotid artery in response to U46619 (data not shown).
Discussion
There are several new findings in the present study. First, the relaxation of the carotid artery in response to acetylcholine is impaired in Rϩ/Aϩ mice. In contrast, vasorelaxation in response to 2 endothelium-independent agonists, nitroprusside and papaverine, were not altered in Rϩ/Aϩ mice. These findings indicate that vascular changes in Rϩ/Aϩ are selective for endothelium and do not reflect some nonspecific alteration in vascular muscle. Second, altered responses of the carotid artery to acetylcholine in Rϩ/Aϩ mice can be restored toward normal with indomethacin. These findings suggest that activity of the cyclooxygenase pathway contributes to vascular dysfunction in Rϩ/Aϩ mice.
Potential Advantages of Studies Using R؉/A؉ Mice
Although some studies have examined endothelial function in carotid artery and intracerebral blood vessels previously, we suggest that the present approach of using mice that overexpress human renin and human angiotensinogen has distinct advantages. For example, in relation to studies of hypertension, the Rϩ/Aϩ mouse represents a defined model in comparison to the commonly used SHR and SHRSP. SHR and SHRSP are models in which hypertension has an unknown etiology and in which the genetic background is quite dissimilar to WKY. 6 Increasing evidence suggests that genetic background is an important additional variable in studies of cardiovascular biology. For example, genetic background differences with respect to susceptibility to atherosclerosis and vascular responses to acetylcholine have been described. [15] [16] [17] In the present study we generated double transgenic mice (Rϩ/Aϩ) (and littermates that were used as controls) by crossbreeding human renin (Rϩ) mice with human angiotensinogen (Aϩ) mice, as we have reported. 8, 9 The genetic background of Rϩ/Aϩ transgenic mice is nearly identical to that in the control animals since the mice used in these studies were derived from 4 to 5 generations of back-crossbreeding to C57BL/6J. With additional backcrossbreeding, future studies will be able to use mice with even greater homogeneity in the genetic background. Because previous studies examining effects of hypertension in SHR versus WKY have used strains that are genetically diverse, the results are clouded by the presence of genes in the genetic background that may themselves predispose or protect from hypertension or endothelial dysfunction.
Vascular Responses in Control and R؉/A؉ Mice
In control mice, acetylcholine, nitroprusside, and papaverine all produced marked relaxation of the carotid artery. Relaxation of the carotid artery in response to acetylcholine was not affected significantly by indomethacin. We have shown previously, using pharmacological approaches and endothelial nitric oxide synthase (eNOS)-deficient mice, that relaxation of the carotid artery in response to acetylcholine is mediated by endogenous production of nitric oxide (by eNOS) and activation of soluble guanylate cyclase. 11 Vasorelaxation in response to nitroprusside (a donor of nitric oxide) is also mediated by activation of soluble guanylate cyclase. 11,18 Because we have not repeated these experiments in Rϩ/Aϩ mice, we assume that vasorelaxation in response to acetylcholine is mediated via the same mechanism in Rϩ/Aϩ mice as in nontransgenic mice. In contrast to acetylcholine and nitroprusside, papaverine produces vasorelaxation that is endothelium independent and is not dependent on activity of soluble guanylate cyclase. 18 Endothelium-dependent relaxation is impaired in most studies of experimental animals and humans with chronic hypertension. 19 -23 For example, we and others have shown that dilatation of the basilar artery and cerebral arterioles 24 -26 in response to endothelium-dependent agonists is impaired in SHRSP. In addition, impaired relaxation of the carotid artery in response to acetylcholine has been observed in SHR and SHRSP 27, 28 and in rats with renovascular hypertension 29 or deoxycorticosterone salt-induced hypertension. 30 In contrast to endothelium-dependent stimuli, vasorelaxation in response to endothelium-independent agonists has been found to be relatively normal during chronic hypertension in most studies, 19 -26 which suggests that impairment of vascular function occurs primarily at the level of endothelium. In the present study we found that relaxation of the carotid artery in response to acetylcholine was impaired and responses to nitroprusside and papaverine were similar in control and Rϩ/Aϩ mice. These new findings support the general concept that chronic hypertension is associated with endothelial dysfunction.
Recently, studies of endothelial function have been performed in a related model, transgenic rats that overexpress the mouse Ren2 gene [TGR(mRen2)27]. The results of these studies have been inconsistent in relation to findings on endothelial function. Endothelium-dependent relaxation in response to acetylcholine has been reported to be impaired in one study of aorta. 31 In contrast, responses to endothelium-dependent agonists in TGR(mRen2)27 were not impaired in another study of aorta 32 and studies of coronary arteries 33 and the mesenteric circulation. 34 Responses to endothelium-dependent agonists were enhanced in the renal circulation of TGR(mRen2)27 compared with nontransgenic controls. 35 The explanation for why inconsistent results have been obtained in studies of endothelial function in TGR(mRen2)27 is not clear.
There have been very few studies of endothelial function in chronically hypertensive mice. In normal mice in which hypertension is produced by psychosocial stress, relaxation to acetylcholine in aorta and hind limb is paradoxically increased. 36 Some data are available on vascular responses to endothelium-dependent agonists in other mice that are chronically hypertensive. For example, endothelial function has been studied in eNOS-and cGMP-dependent protein kinase I-deficient mice, which are moderately hypertensive compared with Rϩ/Aϩ mice. 37, 38 Because responses to acetylcholine are completely abolished in the absence of these essential signaling mechanisms, 11, 14, 37, 38 these data are difficult to compare with the present findings. Thus, the effect of chronic hypertension on eNOS/cGMP signaling in blood vessels cannot be assessed in these models.
Mechanisms of Endothelial Dysfunction in R؉/A؉ Mice
Several studies have attempted to define mechanisms that account for impaired endothelium-dependent relaxation in blood vessels during chronic hypertension. These mechanisms include production of an endothelium-derived contracting factor produced through the cyclooxygenase pathway, 10, 19, 20 degradation of nitric oxide by superoxide anion, 39 and decreased expression of eNOS. 40 In cerebral arterioles of SHR and SHRSP, impaired responses to endothelium-dependent agonists can be restored toward normal with indomethacin. 10, 25 To our knowledge, only 1 study examined mechanisms of carotid vascular dysfunction during hypertension and reported that impaired relaxation in response to acetylcholine in SHR was not altered by indomethacin. 28 In contrast, we found that responses of the carotid artery to acetylcholine could be restored toward normal with indomethacin in Rϩ/Aϩ mice. Thus, our findings differ in terms of mechanism when compared with the results obtained in carotid artery of SHR rats, thereby lending novelty to the present study. Our findings, using a model with better control of genetic background, support the overall concept that activity of cyclooxygenase contributes to vascular dysfunction during chronic hypertension.
In humans with essential hypertension, endotheliumdependent relaxation is impaired. 41, 42 Although several mechanisms have been proposed to account for this abnormality, 41, 42 indomethacin restores impaired endotheliumdependent responses toward normal in patients with hypertension. 43, 44 Thus, the findings in the present study in Rϩ/Aϩ mice are consistent with data in at least some patients with hypertension and support that concept that impaired endothelial function in hypertension can be mediated, at least in part, by increased activity of cyclooxygenase.
In summary, endothelial function is impaired selectively in transgenic mice that express human renin and human angiotensinogen. The mechanism of this impairment may involve production of a cyclooxygenase-derived contracting factor.
